We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

Back to rankings

46 hedge funds and large institutions have $22.3M invested in EnteroMedics Inc. in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more call options, than puts

Call options by funds: $225K | Put options by funds: $151K

13% more capital invested

Capital invested by funds: $19.8M → $22.3M (+$2.53M)

6% less funds holding

Funds holding: 49 → 46 (-3)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
9
Closed
10
Calls
$225K
Puts
$151K
Net Calls
+$74K
Net Calls Change
-$401K

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$494K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$189K
3
IHM
Iguana Healthcare Management
New York
+$130K
4
OAM
Oxford Asset Management
United Kingdom
+$37.8K
5
PP
Paloma Partners
Connecticut
+$36.5K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$798K
2
Wells Fargo
Wells Fargo
California
-$161K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
-$143K
4
HLA
Hamilton Lane Advisors
Pennsylvania
-$136K
5
Goldman Sachs
Goldman Sachs
New York
-$109K
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
26
Two Sigma Securities
New York
$31K +$28.4K +21 New
BW
27
Bison Wealth
Georgia
$30K +$27K +20 New
UBS Group
28
UBS Group
Switzerland
$24K +$21.6K +16 New
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
$22K – – –
RNS
30
Robert N. Shapiro
$20K – – –
ST
31
Spot Trading
Illinois
$19K -$5.4K -4 -24%
State Street
32
State Street
Massachusetts
$18K -$2.7K -2 -14%
Goldman Sachs
33
Goldman Sachs
New York
$16K -$109K -81 -88%
Morgan Stanley
34
Morgan Stanley
New York
$15K -$60.8K -45 -82%
GC
35
Guggenheim Capital
Illinois
$15K +$13.5K +10 New
BIM
36
BlackRock Investment Management
Delaware
$14K – – –
Simplex Trading
37
Simplex Trading
Illinois
$13K +$10.8K +8 New
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$8K – – –
Deutsche Bank
39
Deutsche Bank
Germany
$7K – – –
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$4K – – –
TWA
41
TCI Wealth Advisors
Arizona
$4K – – –
AIG
42
American International Group
New York
$1.42K – – –
Canada Life
43
Canada Life
Manitoba, Canada
$1K – – –
Creative Planning
44
Creative Planning
Kansas
$1K – – –
US Bancorp
45
US Bancorp
Minnesota
$1K – – –
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
RA
47
Royce & Associates
New York
– -$798K -618 Closed
HLA
48
Hamilton Lane Advisors
Pennsylvania
– -$136K -106 Closed
VKH
49
Virtu KCG Holdings
New York
– -$35K -28 Closed
Group One Trading
50
Group One Trading
Illinois
– -$29.7K -22 Closed
1
2
3

ETRM Hedge Fund Activity: Q4 2014 in Review

46 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q4 2014, worth a combined $22.3M — up 13% from $19.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ETRM and 8 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Fred Alger Management, adding an estimated $494K. The largest seller was Royce & Associates, exiting entirely with an estimated $798K sold.

  • 46 institutional investors held EnteroMedics Inc. (ETRM) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $22.3M of EnteroMedics Inc. stock for Q4 2014, up 13% quarter-over-quarter.
  • 8 funds opened new EnteroMedics Inc. positions in Q4 2014 and 10 closed out, a net change of -2 holders.
  • The largest EnteroMedics Inc. buyer in Q4 2014 was Fred Alger Management, an estimated $494K added.
  • The largest EnteroMedics Inc. seller in Q4 2014 was Royce & Associates, an estimated $798K sold.

Based on aggregated 13F filings for Q4 2014.